Welcome to UniTaq Bio

About Us

Reinventing PCR

UniTaq Bio holds two US patents*:

 1. Methods and compositions for universal detection of nucleic acids https://patents.google.com/patent/US8940487B2 and
2. Methods and compositions for PCR using blocked and universal primers: https://patents.google.com/patent/US9523121B2 

* European equivalents are pending

Business opportunities

These patents are available for licensing for these applications:

1. Infections disease diagnostics, including drug resistance testing; 

2. Non-invasive prenatal testing (NIPT) for chromosomal aneuploidies, e.g., Down syndrome; 

3. Companion Dx: somatic mutation, gene expression, methylation, copy number variation; 

4. Closed tube target enrichment for NGS (next generation sequencing) that prevents sample contamination; can be used to detect somatic mutations in plasma.  

Company info

UniTaq Bio received a SBIR grant.

Co-founders: 

Gene Spier: https://www.linkedin.com/in/genespier/

Alain Mir: https://www.linkedin.com/in/alain-mir-2374bb1/

Subscribe

Sign up to hear from us about specials, sales, and events.

Contact Us

Drop us a line!

UniTaq Bio

400 Magdalena Ave., Los Altos, CA 94024, US

(650) 949-1188